R. Gidwani

发表

Impact of Scribes on Physician Satisfaction, Patient Satisfaction, and Charting Efficiency: A Randomized Controlled Trial

Risha Gidwani, Steven Lin, Cathina Nguyen, 2017, The Annals of Family Medicine.

Cost-Effectiveness of Treatments for Genotype 1 Hepatitis C Virus Infection in Non-VA and VA Populations

Vilija R. Joyce, D. Owens, S. Asch, 2016, MDM policy & practice.

Association between aggressive care and bereaved families’ evaluation of end‐of‐life care for veterans with non‐small cell lung cancer who died in Veterans Affairs facilities

Susan C. Miller, T. Wagner, B. Kinosian, 2017, Cancer.

PIH13 THE COST-EFFECTIVENESS OF THE LEVONORGESTREL-RELEASING INTRAUTERINE SYSTEM (LNG-IUS, MIRENA®) FOR THE TREATMENT OF HEAVY MENSTRUAL BLEEDING IN THE UNITED STATES

M. Ganz, A. Filonenko, J. Pocoski, 2011 .

Evaluating Two Measures of Lumbar Spine MRI Overuse: Administrative Data Versus Chart Review.

P. Barnett, T. Avoundjian, Patricia L. Sinnott, 2016, Journal of the American College of Radiology : JACR.

Uptake and utilization of directly acting antiviral medications for hepatitis C infection in U.S. veterans

D. Owens, S. Asch, P. Barnett, 2015, Journal of viral hepatitis.

Multifaceted academic detailing program to increase pharmacotherapy for alcohol use disorder: interrupted time series evaluation of effectiveness

Alex H. S. Harris, C. Rosen, H. Hagedorn, 2016, Addiction Science & Clinical Practice.

Health insurance and financial hardship in cancer survivors during the COVID-19 pandemic

Courtney P. Williams, M. Halpern, Janet S. de Moor, 2022, PloS one.

The cost-effectiveness of the levonorgestrel-releasing intrauterine system for the treatment of idiopathic heavy menstrual bleeding in the United States.

M. Ganz, A. Filonenko, J. Pocoski, 2013, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

A cost-effectiveness analysis of using azacitidine vs. decitabine in treating patients with myelodysplastic syndromes

C. Pashos, P. Fenaux, Z. Khan, 2012, Journal of medical economics.

Estimating Transition Probabilities from Published Evidence: A Tutorial for Decision Modelers

Louise B. Russell, Risha Gidwani, L. Russell, 2020, PharmacoEconomics.

The Appropriate Provision of Primary versus Specialist Palliative Care to Cancer Patients: Oncologists' Perspectives.

K. Ramchandran, S. Asch, C. Timko, 2017, Journal of palliative medicine.

The use of bone morphogenetic protein in thoracolumbar spine procedures: analysis of the MarketScan longitudinal database.

J. Ratliff, A. Veeravagu, B. Jiang, 2014, The spine journal : official journal of the North American Spine Society.

A provider participatory implementation model for HIV testing in an ED.

S. Asch, M. Goetz, H. Anaya, 2011, American Journal of Emergency Medicine.

The economic burden of metastatic breast cancer: a systematic review of literature from developed countries.

Jeffrey D. Miller, M. Russell, T. Foster, 2011, Cancer treatment reviews.

Clinical trial representativeness and treatment intensity in a real-world sample of women with early stage breast cancer

Jeffrey A. Franks, Courtney P. Williams, A. Azuero, 2021, Breast Cancer Research and Treatment.

End‐of‐Life Cost Trajectories in Cancer Patients Treated by Medicare versus the Veterans Health Administration

K. Ramchandran, T. Wagner, S. Asch, 2020, Journal of the American Geriatrics Society.

Use of mixed-treatment-comparison methods in estimating efficacy of treatments for heavy menstrual bleeding

D. Hoaglin, M. Glickman, R. Wasiak, 2013, European Journal of Medical Research.

Gap between Recommendations and Practice of Palliative Care and Hospice in Cancer Patients.

Susan C. Miller, T. Wagner, B. Kinosian, 2016, Journal of palliative medicine.

Hesitancy and malignancy: Vaccine hesitancy among individuals with cancer.

F. Fletcher, Courtney P. Williams, A. Azuero, 2021, Journal of Clinical Oncology.

Inappropriate ordering of lumbar spine magnetic resonance imaging: are providers Choosing Wisely?

P. Barnett, T. Avoundjian, Patricia L. Sinnott, 2016, The American journal of managed care.

Survival in the Real World: A National Analysis of Patients Treated for Early-Stage Breast Cancer

Jeffrey A. Franks, Courtney P. Williams, A. Azuero, 2021, JCO oncology practice.

CMS Reimbursement Reform and the Incidence of Hospital-Acquired Pulmonary Embolism or Deep Vein Thrombosis

J. Bhattacharya, R. Gidwani, 2015, Journal of general internal medicine.

A budget impact analysis of rapid human immunodeficiency virus screening in Veterans Administration emergency departments.

Steven Asch, Risha Gidwani, Jack Needleman, 2012, The Journal of emergency medicine.

Clinical trial representativeness and treatment intensity in a real-world sample of women with early-stage breast cancer.

Courtney P. Williams, A. Azuero, G. Rocque, 2021 .

Original article A cost-effectiveness analysis of using azacitidine vs. decitabine in treating patients with myelodysplastic syndromes

P. Fenaux, Z. Khan, R. Gidwani, 2012 .

The rise of concurrent care for veterans with advanced cancer at the end of life

Susan C. Miller, B. Kinosian, V. Mor, 2016, Cancer.